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VALVULAR AND STRUCTURAL HEART DISEASES
Case Report
Intravascular Ultrasound-Guided Stenting of Left Main
Stem Dissection After Medtronic Corevalve Implantation
N.M. Van Mieghem* and P.P. de Jaegere
Transcatheter aortic valve implantation (TAVI) implies the introduction, positioning, and
deployment of a stented bioprosthesis in the (calcified) native aortic valve. We report
an at first glance uneventful TAVI with the Medtronic Corevalve System, which was fol-
lowed by transient electrocardiographic changes suggesting acute left main stem dis-
ease. The diagnosis of acute left main stem dissection extending from the left coro-
nary cusp was firmly established by intravascular ultrasound. The ostium of the left
main stem was successfully treated with intravascular ultrasound-guided placement of
a drug eluting stent. VC 2013 Wiley Periodicals, Inc.
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INTRODUCTION
Transcatheter aortic valve implantation (TAVI) has
become an accepted treatment option for elderly patients
with symptomatic severe aortic valve stenosis (AS) with a
prohibitive or high operative risk [1,2]. A TAVI proce-
dure still is a fairly complex procedure mandating appro-
priate patient selection, meticulous pre-procedural plan-
ning (risk stratification, imaging), and knowledge of a
wider spectrum of interventional tools and techniques.
The growing global experience has illustrated potential
TAVI-related complications [3]. In this case report, we
describe the occurrence and treatment of an acute left
main stem dissection following successful TAVI with the
Medtronic Corevalve SystemTM (MCS) (Medtronic
Corp., Minnesota, MN) and illustrate the feasibility and
value of intravascular ultrasound (IVUS) for diagnosis
and treatment in this particular setting.
CASE REPORT
An 86-year-old female patient presented to the outpa-
tient clinic because of worsening angina (CCS class 3) and
dyspnea (NYHA class 3). Transthoracic echocardiography
confirmed severe AS with a transaortic peak velocity 4.7
m/sec and measured aortic valve area 0.7 cm2. Diagnostic
coronary angiography demonstrated a right dominant coro-
nary system with diffusely heavily calcified non-obstruc-
tive coronary artery disease. Over the last years, she had
developed invalidating poly-arthritis for which total knee
prosthesis was scheduled. She was discussed in the heart
valve team. The Logistic EuroSCORE was 11.4% and the
Society of Thoracic Surgeons (STS) score was 4.2%. She
was walking aid dependent and therefore considered to be
frail. With this global clinical picture in mind a consensus
for TAVI was reached.
The aortic annulus size was measured 27 mm  24 mm
with pronounced aortic root calcification and properly sized
common femoral arteries as determined by baseline Multi-
Slice Computed Tomography scan. The patient was con-
sidered a good candidate for TAVI with the MCS.
Details of the MCS TAVI have previously been
described [4]. The procedure evolved under general
anesthesia. After Echo guided access to the common
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femoral artery and the introduction of a transvenous
temporary pacemaker into the right ventricular apex,
the native aortic valve was retrogradely crossed with
an extra support long guidewire. Under rapid burst pac-
ing balloon, aortic valvuloplasty was performed using
a Green Arrow PBAV-26TM-balloon (SYMTM, Lifetech
Scientific Co., Ltd), which was gradually inflated up to
24 mm diameter (Fig. 1). A 29-mm MCS was then
positioned and deployed. Control aortogram demon-
strated at least moderate aortic regurgitation (AR)
(Fig. 2). A rotational angiogram suggested localized
prosthesis underexpansion (Fig. 3). We decided to
postdilate the prosthesis with the Green Arrow PBAV-
26TM-balloon up to 26 mm diameter (Fig. 4). The final
aortogram showed adequate MCS positioning with no
residual AR and clear visibility of both coronaries
(Fig. 5). After vascular closure of the groin, the patient
was weaned uneventfully. In the following hours, she
developed waxing and waning chest discomfort with
accompanying dynamic ST-T changes on sequential elec-
trocardiograms (Fig. 6, upper and lower panels). The tran-
sient diffuse ST-depressions with ST-elevation in aVR
were reminiscent of a left main stem problem. The patient
was brought back to the catheterization laboratory. An
Amplatz Left 1 guiding catheter was selected to cautiously
maneuver through the MCS frame struts. A subselective
angiogram confirmed a left main stem dissection (Fig. 7).
In order not to distort the framework, we opted to wire the
left main stem with the guiding catheter fixated in a subse-
lective position through the struts. A High Torque Whisper
Extra-Support coronary guidewire was advanced into the
left anterior descending artery and a Pilot-50 coronary
guidewire into the left circumflex artery. IVUS confirmed
a dissection entry port in the left sinus of Valsalva perpetu-
ating into the left main stem (Fig. 8). Of note, the distal left
main bifurcation was not affected which allowed for a
Fig. 2. Corevalve in situ with at least moderate aortic regur-
gitation (arrow).
Fig. 3. Still frame taken from rotational angiogram; the dot-
ted lines illustrate the frame underexpansion.
Fig. 4. Postdilatation of the medtronic corevalve.
Fig. 1. Balloon aortic valvuloplasty.
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selected stent size to land before the bifurcation. After pre-
dilation with a 2.5 mm  12 mm non-compliant Voyager
Balloon, a Xience Prime 4.0 mm  12mm drug eluting
stent was implanted into the ostial left main stem, followed
by postdilation with a 4.0 non-compliant Voyager Balloon
(Fig. 9). IVUS confirmed the good final angiographic result
with adequate stent apposition (Fig. 10).
DISCUSSION
TAVI is a catheter bound minimally invasive alterna-
tive to surgical aortic valve replacement for selected
patients with higher operative risk. Two conceptually
different valve systems have Conformite´ Europe´enne
(CE) mark approval: the Edwards SAPIENTM (Edwards
Life-sciences, Irvine, CA) is a balloon expandable
device whereas the Medtronic Corevalve SystemTM is
self-expandable. Apart from the fundamentally different
implantation technique, both devices have specific
device and procedure-related complications.
In the present case report, we describe the occurrence
of left main stem dissection after MCS TAVI. Immedi-
ate TAVI-related coronary complications are a rare en-
tity and the etiology can be diverse: coronary obstruc-
tion by native aortic valve leaflets or attached calcium
deposits, true embolization of calcium debris into the
coronary arterial bed, aortic dissection extending into
one of the coronary ostia, mechanical obstruction of the
coronary ostia by an excessively high implanted valve
prosthesis, etc. [3]. Baseline multi-modality imaging can
help in risk stratification of these particular complica-
tions: the length of the native aortic leaflets can be
measured and compared with the distance from the vir-
tual aortic annulus to the ostium of the right and left cor-
onary artery (the so-called coronary height), qualitative
and (semi-) quantitative analysis of the calcium burden
can guide operators, the respective sizes of the aortic
annulus, aortic sinuses, sino-tubular junction and
ascending aorta can be measured etc. [5].
The pathophysiology in the case described above
was illustrated by IVUS. One has to keep in mind that
the Medtronic Corevalve framework anchors itself in
the aortic root and will in principle not touch the mar-
gins of the wider aortic sinuses where the right and left
coronary arteries originate. During a postdilatation ma-
neuver with a non-compliant balloon, the framework is
briefly expanded with excessive force against the aortic
wall potentially touching the wall of the aortic sinuses.
Fig. 5. Aortogram after postilating the medtronic corevalve.
White arrow: left coronary artery. Arrow head: no contrast in
the left ventricle.
Fig. 6. Upper panel: baseline ECG. Lower panel: dynamic ST
depressions V3-6, I, II, and aVF. ST elevation in aVR.
Fig. 7. Coronary angiogram in ‘‘spider view’’ of left main
stem. Arrow: dissection of proximal left main stem.
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Theoretically this maneuver can crack calcified struc-
tures and create dissections of the ascending aorta and/
or the ostium of a coronary artery as happened here.
Postdilatation of an MCS prosthesis is required in
approximately 15% of cases. In our series of 180 MCS
TAVI cases, we encountered only 1 MCS postdilata-
tion complicated by a coronary dissection, suggesting
it is truly a rare event. The considerable clinical impact
however warrants special attention.
In this case, the coronary arteries were accessible
with guiding catheters through the MCS struts. We
deliberately chose not to distort the framework and
therefore parked the guiding catheter in front of an
open MCS strut in line with the coronary ostia. Coro-
nary stent implantation and final IVUS confirmation
evolved unremarkably.
Percutaneous coronary intervention (PCI) after MCS
TAVI has been described previously. The Siegburg
group has demonstrated the feasibility of left main
stenting through the MCS frame of a previously
bypassed left main stem lesion [6]. Other groups
reported successful PCI after both MCS TAVI [7] and
Edwards SAPIEN TAVI [8,9].
IVUS is feasible after MCS TAVI and holds several
assets. In this case report, it helped elucidate the patho-
physiology of the left main stem dissection and also
provided invaluable information to guide optimal stent
size selection. The need for stenting across the distal
left main bifurcation would have made the PCI much
more complex with potential suboptimal results on the
longer term (higher risk of major adverse events).
This case report underscores the importance of close
follow-up of patients during the early days following
Fig. 8. IVUS pull-back from the left main stem into the left coronary cusp of the aorta. Left
panel: IVUS frame taken in the sinus of valsalva (only aortic wall partially visible). Arrow
shows dissection entry port. Middle panel: Ostium of the left main stem with dissection
(arrow). Right panel: Fibro-calcific dissection flap in the left main stem (arrow).
Fig. 9. Coronary angiogram in ‘‘spider view’’ of the left main
stem after stenting.
Fig. 10. IVUS confirming good stent apposition in the left
main stem.
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successful TAVI and the ability to respond to specific
clinical and electrocardiographic signs, which may sug-
gest potentially life-threatening events. To the best of
our knowledge, we report for the first time the feasibil-
ity and value of IVUS in the evaluation of an iatro-
genic left main stem dissection after MCS TAVI.
IVUS guided emergent PCI appears safe and feasible
within the first days after MCS TAVI.
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